{"id": "batch_req_Cilt8gsEitg9pcoqFB2EAfup", "custom_id": "0_coral_summary_0.0_gpt-4-turbo", "response": {"status_code": 200, "request_id": "fdcf0832a26e6743fbb477814abd6332", "body": {"id": "chatcmpl-9e3mRgpN0RGCEAAr7PFubUdyVS4R3", "object": "chat.completion", "created": 1719334679, "model": "gpt-4-turbo-2024-04-09", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Summary:\nAge: 56 years\nGender: Female\nCancer diagnosis: Stage II right breast cancer initially diagnosed in May 2013, now with metastatic relapse involving lungs, peritoneum, liver, and ovary, with local recurrence near the right axilla and implant.\nPMH: Anxiety, hyperlipidemia\nPrior cancer treatments: Mastectomy with sentinel node and implant reconstruction in June 2013. Declined adjuvant therapy and tamoxifen.\nCurrent cancer treatments: Pending biopsy and further staging to guide treatment; discussed potential use of Ibrance if HR+/HER2- confirmed.\nCurrent medication list: No current medications; patient takes a long list of supplements.\nSummary of most recent oncology visit (12/30/2019): 56-year-old female with a history of Stage II right breast cancer, now presenting with metastatic relapse. She is scheduled for a biopsy of the right axilla and further staging. Treatment options discussed, focusing on palliative care to improve quality and length of life. Patient appears anxious but has good support from her husband."}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 2340, "completion_tokens": 223, "total_tokens": 2563}, "system_fingerprint": "fp_9d7f5c6195"}}, "error": null}
{"id": "batch_req_PZeY1DNuA0IgXHoNadzOrT04", "custom_id": "1_coral_summary_0.0_gpt-4-turbo", "response": {"status_code": 200, "request_id": "9d3224abfcfbaedbfa80f26273ecac66", "body": {"id": "chatcmpl-9e3mamYg2wrhwbHg6eL6JKaQs7HKI", "object": "chat.completion", "created": 1719334688, "model": "gpt-4-turbo-2024-04-09", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Summary:\nAge: 44 years\nGender: Female\nCancer diagnosis: Metastatic breast cancer, early stage endometrial cancer, colon cancer\nPMH: Lynch Syndrome, anemia, peripheral neuropathy, anxiety, hot flashes, chronic headaches, hyponatremia, hypokalemia\nPrior cancer treatments: Neoadjuvant therapy, partial mastectomy, adjuvant therapy, gemcitabine + carboplatin, Abraxane and Pembrolizumab\nCurrent cancer treatments: Irinotecan started on 06/30/19, modified to every other week due to poor tolerance\nCurrent medication list: Albuterol, Ambien CR, cyclobenzaprine, diphenoxylate-atropine, docusate sodium, gabapentin, lidocaine-prilocaine, loperamide, lorazepam, lurasidone, magnesium oxide, morphine, omeprazole, ondansetron, oxycodone, polyethylene glycol, pregabalin, prochlorperazine, rivaroxaban, simethicone, venlafaxine (discontinued), naloxone\nSummary of most recent oncology visit: 44-year-old female with Lynch Syndrome, early stage endometrial and colon cancer, and newly diagnosed metastatic breast cancer. She is currently on cycle 3 day 1 of Irinotecan, modified due to side effects. She presents with increased chest wall tenderness, erythema, and edema, treated with Doxycycline. Experiencing worsening back pain, anemia treated with 1 unit pRBC, and peripheral neuropathy. MRI shows numerous bone marrow replacing lesions. Plans include re-evaluation for radiation therapy, monitoring of liver function and hepatitis B status, and follow-up in 2 weeks."}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5742, "completion_tokens": 382, "total_tokens": 6124}, "system_fingerprint": "fp_5a244dacc1"}}, "error": null}
{"id": "batch_req_a1AIC2EFVAxXPAeScZqX4UnA", "custom_id": "2_coral_summary_0.0_gpt-4-turbo", "response": {"status_code": 200, "request_id": "3ca79490f42235882f2c1f156e60fe48", "body": {"id": "chatcmpl-9e3mSQRhf2VK1oqnonKbFSiBs2HdF", "object": "chat.completion", "created": 1719334680, "model": "gpt-4-turbo-2024-04-09", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Summary:\nAge: 53 years\nGender: Female\nCancer diagnosis: Stage IIA invasive ductal carcinoma (IDC) of the right breast, hormone receptor-positive (HR+), HER2-neu negative\nPMH: Hyperlipidemia, pre-diabetes\nPrior cancer treatments: None\nCurrent cancer treatments: Discussed neoadjuvant therapy, chemotherapy, surgery, radiation, and hormonal blockade\nCurrent medication list: None on file\nSummary of most recent oncology visit (08/31/2021): 53-year-old female with newly diagnosed Stage IIA HR+ HER2-neu negative IDC of the right breast. Discussed treatment options including chemotherapy, surgery, radiation, and hormonal therapy to reduce risks of local and systemic recurrence. Genetic testing and PET CT are pending. Recommended lifestyle modifications for cancer risk reduction. No current medications. Good support system. Follow-up planned after pending tests. Consultation conducted via telehealth.\nFamily history: Leukemia in father, breast cancer in paternal and maternal aunts\nSocial history: Never smoker, no alcohol or drug use, single, no children\nAllergies: No known allergies\nPerformance status: Asymptomatic (0)\nLifestyle: Occasionally walks, moderate sweet tooth, sleeps 5-6 hours, medium stress level\nPhysical exam: No acute distress, appears stated age, no vitals taken during this telehealth visit"}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1640, "completion_tokens": 287, "total_tokens": 1927}, "system_fingerprint": "fp_5a244dacc1"}}, "error": null}
{"id": "batch_req_h18dxgXb3IQbU6E8skPeBER5", "custom_id": "3_coral_summary_0.0_gpt-4-turbo", "response": {"status_code": 200, "request_id": "ee111a5a47e2152ad892bf31a268bd86", "body": {"id": "chatcmpl-9e3mjymW9ErNLvuWyTQFfCUN47YRM", "object": "chat.completion", "created": 1719334697, "model": "gpt-4-turbo-2024-04-09", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Summary:\nAge: 75 years\nGender: Female\nCancer diagnosis: ER+/PR+/HER2- left breast invasive ductal carcinoma\nPMH: hypertension, hypercholesterolemia, allergic rhinitis, osteoporosis\nPrior cancer treatments: Left mastectomy with SLN biopsy (completed on 10/29/2016)\nCurrent cancer treatments: Letrozole (started 12/02/2016)\nCurrent medication list: aspirin, calcium carbonate, cholecalciferol (vitamin D3), letrozole, loratadine, metoprolol succinate, metoprolol tartrate, pravastatin\nSummary of most recent oncology visit: 75-year-old female with a history of left breast invasive ductal carcinoma, post-mastectomy, currently on Letrozole. No evidence of disease recurrence. She reports improvement in pain after physical therapy and uses non-pharmacological methods for muscle cramps and headaches. Advised to continue current treatment and follow-up in 6 months or sooner if symptoms worsen."}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 2752, "completion_tokens": 223, "total_tokens": 2975}, "system_fingerprint": "fp_9d7f5c6195"}}, "error": null}
{"id": "batch_req_c02ppjvAnsYISjuaG4eBI26s", "custom_id": "4_coral_summary_0.0_gpt-4-turbo", "response": {"status_code": 200, "request_id": "7b7aa2da76a646aa251857b8e04a15de", "body": {"id": "chatcmpl-9e3mtQ6WUJB4cWG65BaCrCYGQ0i8S", "object": "chat.completion", "created": 1719334707, "model": "gpt-4-turbo-2024-04-09", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Summary:\nAge: 31 years\nGender: Female\nCancer diagnosis: Stage III ER+/PR+ HER2- Invasive Ductal Carcinoma (IDC) of the left breast, now with biopsy-proven metastatic recurrence involving left cervical lymph node\nPMH: None specified\nPrior cancer treatments: Bilateral mastectomies, adjuvant chemotherapy with Adriamycin/cytoxan (stopped after 3 cycles due to severe side effects), anti-estrogen therapy (leuprolide, exemestane, tamoxifen)\nCurrent cancer treatments: Leuprolide (started January 2019), anastrozole (started March 2019), palbociclib (started April 2019)\nCurrent medication list: amlodipine, anastrozole, escitalopram, gabapentin, hydrochlorothiazide, ondansetron, palbociclib, potassium chloride, venlafaxine\nSummary of most recent oncology visit (12/07/2019): 31-year-old premenopausal female with a history of Stage III ER+/PR+ HER2- IDC of the left breast, now presenting with metastatic recurrence. She is currently on leuprolide, anastrozole, and palbociclib, and tolerating the therapy well. Plans include continuation of current therapy, monthly labs coinciding with lupron injections, and restaging studies before the next visit. Referral to radiation oncology for symptomatic disease in her left neck and brachial plexus has been made."}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 3407, "completion_tokens": 334, "total_tokens": 3741}, "system_fingerprint": "fp_5a244dacc1"}}, "error": null}
{"id": "batch_req_VbfeIevkrb8icmeUG8ROPvGU", "custom_id": "0_coral_summary_0.7_gpt-4-turbo", "response": {"status_code": 200, "request_id": "65b791efb59ecae47ab47ec4160d8d37", "body": {"id": "chatcmpl-9e3n6uYo04iO72YormrSkQm7OUDkz", "object": "chat.completion", "created": 1719334720, "model": "gpt-4-turbo-2024-04-09", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Summary:\nAge: 56 years\nGender: Female\nCancer diagnosis: Stage II right breast cancer initially diagnosed in May 2013, now presenting with metastatic relapse involving lungs, peritoneum, liver, and ovary, with regional recurrence near the right axilla and implant. Tumors originally 2.3 and 2.4 cm, node-negative, ER and PR positive, HER2 negative.\nPMH: Anxiety, hyperlipidemia\nPrior cancer treatments: Mastectomy with sentinel node and implant reconstruction in June 2013. Declined tamoxifen and did not receive radiation or chemotherapy.\nCurrent cancer treatments: Pending tissue confirmation and staging workup. Planned treatment with Ibrance if biopsy confirms HR+/HER2-.\nCurrent medication list: Long list of supplements (details not provided in the note)\nAllergies: Penicillins (reaction: rash)\nSummary of most recent oncology visit (12/30/2019): 56-year-old female with a history of Stage II right breast cancer s/p mastectomy, now presenting with metastatic relapse. She is scheduled for a biopsy of the right axilla and further staging workup. Discussed palliative treatment options to improve quality and length of life. Patient appears anxious with good support from her husband. No outpatient medications reported; takes various supplements."}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 2340, "completion_tokens": 276, "total_tokens": 2616}, "system_fingerprint": "fp_5a244dacc1"}}, "error": null}
{"id": "batch_req_UUP8evMGVrRZJN00aCjBwkSp", "custom_id": "1_coral_summary_0.7_gpt-4-turbo", "response": {"status_code": 200, "request_id": "d19dedce286a57b1c2ff4cf97f217140", "body": {"id": "chatcmpl-9e3nJ2Qi33hjsPWGzoJPo6WDrWU9G", "object": "chat.completion", "created": 1719334733, "model": "gpt-4-turbo-2024-04-09", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Summary:\nAge: 44 years\nGender: Female\nCancer diagnosis: Early stage endometrial and colon cancer, metastatic breast cancer\nPMH: Lynch Syndrome\nPrior cancer treatments: Neoadjuvant therapy, partial mastectomy, adjuvant chemotherapy, gemcitabine + carboplatin, Abraxane and Pembrolizumab\nCurrent cancer treatments: Started Irinotecan on 06/30/19\nCurrent medication list: Albuterol, Ambien CR, cyclobenzaprine, diphenoxylate-atropine, docusate sodium, gabapentin, lidocaine-prilocaine, loperamide, lorazepam, lurasidone, magnesium oxide, morphine, omeprazole, ondansetron, oxycodone, polyethylene glycol, pregabalin, prochlorperazine, rivaroxaban, simethicone, Effexor-XR (venlafaxine discontinued)\nSummary of most recent oncology visit: 44-year-old female with Lynch Syndrome, early stage endometrial and colon cancer, and newly diagnosed metastatic breast cancer on Irinotecan. Reports multiple symptoms including confusion, chest pain, severe back pain, anxiety, and depression. Current treatment plan includes continuation of Irinotecan, management of pain and symptoms, and monitoring. MRI pending for further evaluation. Patient education and counseling provided during visit."}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5742, "completion_tokens": 297, "total_tokens": 6039}, "system_fingerprint": "fp_9d7f5c6195"}}, "error": null}
{"id": "batch_req_ObNA9L1ARKv85FrPGROLsWyn", "custom_id": "2_coral_summary_0.7_gpt-4-turbo", "response": {"status_code": 200, "request_id": "7fbe178ae54e5eb53ca21e751da0d0dd", "body": {"id": "chatcmpl-9e3nWPWByGRM2cW6eOOL8HhQVmURq", "object": "chat.completion", "created": 1719334746, "model": "gpt-4-turbo-2024-04-09", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Summary:\nAge: 53 years\nGender: Female\nCancer diagnosis: Stage IIA invasive ductal carcinoma (IDC) of the right breast, hormone receptor-positive, HER2-neu negative\nPMH: Hyperlipidemia, pre-diabetes\nPrior cancer treatments: None\nCurrent cancer treatments: Under discussion (neoadjuvant therapy recommended)\nCurrent medication list: None on file\nSummary of most recent oncology visit (08/31/2021): 53-year-old female with newly diagnosed Stage IIA right IDC of the breast, node positive, HR+, HER2-neu negative. During the telehealth consultation, discussions on chemotherapy, surgery, radiation, and hormonal blockade were held to decrease the risk of both local and systemic recurrence. Lifestyle modifications were also recommended. Genetic testing and PET CT are pending. Follow-up planned after results are available.\nFamily history: Leukemia (father), breast cancer (paternal aunt at age 60, maternal aunt)\nSocial history: Never smoker, never alcohol, no drug use, single, no children\nAllergies: No known allergies\nPerformance status: Asymptomatic (0)\nLifestyle: Occasional exercise, moderate sweet consumption, 5-6 hours of sleep with medication, medium stress levels with good support."}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1640, "completion_tokens": 265, "total_tokens": 1905}, "system_fingerprint": "fp_5a244dacc1"}}, "error": null}
{"id": "batch_req_S6jaef8r3Zch7muGjZxonJ1N", "custom_id": "3_coral_summary_0.7_gpt-4-turbo", "response": {"status_code": 200, "request_id": "987b46be001626a8259e05924022d5b6", "body": {"id": "chatcmpl-9e3ni7gVz0KdnNUDfChavnI9jSsxR", "object": "chat.completion", "created": 1719334758, "model": "gpt-4-turbo-2024-04-09", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Age: 75 years  \nGender: Female  \nCancer diagnosis: ER+/PR+/HER2- left breast invasive ductal carcinoma  \nPMH: hypertension, hypercholesterolemia, allergic rhinitis, osteoporosis  \nPrior cancer treatments: Left mastectomy with sentinel lymph node biopsy (10/29/2016)  \nCurrent cancer treatments: Letrozole since 12/02/2016  \nCurrent medication list: Letrozole, aspirin, calcium carbonate, cholecalciferol (vitamin D3), loratadine, metoprolol succinate, metoprolol tartrate, pravastatin  \nSummary of most recent oncology visit: 75-year-old female post-mastectomy for ER+/PR+/HER2- breast cancer, currently on Letrozole. She reports improved pain from physical therapy and no evidence of disease recurrence on recent imaging. Advised to continue Letrozole, annual mammograms, and monitor bone density. Current issues include muscle cramps, back and leg pain, and loose stools, with management plans in place for each. Follow-up in 6 months or as needed."}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 2752, "completion_tokens": 238, "total_tokens": 2990}, "system_fingerprint": "fp_9d7f5c6195"}}, "error": null}
{"id": "batch_req_xqZQTn0zqrWMcGcU4w1q8oeI", "custom_id": "4_coral_summary_0.7_gpt-4-turbo", "response": {"status_code": 200, "request_id": "95135577770b2d7e38952e2de7de4fda", "body": {"id": "chatcmpl-9e3nx18EMvdLkAeBCzZmgf74R1CuR", "object": "chat.completion", "created": 1719334773, "model": "gpt-4-turbo-2024-04-09", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Summary:\nAge: 31 years\nGender: Female\nCancer diagnosis: Stage III ER+/PR+/HER2- invasive ductal carcinoma (IDC) of the left breast, with metastatic recurrence involving left cervical lymph nodes and left brachial plexus\nPMH: None specified\nPrior cancer treatments: Bilateral breast skin-sparing mastectomy, adjuvant chemotherapy with Adriamycin/cyclophosphamide (stopped after 3 cycles due to adverse effects), anti-estrogen therapy (leuprolide, exemestane, tamoxifen)\nCurrent cancer treatments: Leuprolide (since January 2019), anastrozole (since March 2019), palbociclib (since April 2019)\nCurrent medication list: amlodipine, anastrozole, escitalopram, gabapentin, hydrochlorothiazide, ondansetron, palbociclib, potassium chloride, venlafaxine\nSummary of most recent oncology visit (12/07/2019): 31-year-old premenopausal female with a history of stage III ER+/PR+/HER2- IDC of the left breast, now with biopsy-proven metastatic recurrence, currently on leuprolide, anastrozole, and palbociclib. She is symptomatic with neck pain and left arm symptoms due to brachial plexus involvement. She tolerates current therapy and will continue with planned restaging studies and monthly labs on the days of her lupron injections. Referrals to radiation oncology have been made for symptomatic management."}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 3407, "completion_tokens": 339, "total_tokens": 3746}, "system_fingerprint": "fp_5a244dacc1"}}, "error": null}
{"id": "batch_req_nlOryHpb07pLeMUY320sNxtD", "custom_id": "0_coral_summary_1.0_gpt-4-turbo", "response": {"status_code": 200, "request_id": "5c9752b48fbd5493f4ee89909bcd589c", "body": {"id": "chatcmpl-9e3oDkb1AtSLhLQvtQ4YPi9LIHlvc", "object": "chat.completion", "created": 1719334789, "model": "gpt-4-turbo-2024-04-09", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Summary:\nAge: 56 years\nGender: Female\nCancer diagnosis: Stage II right breast cancer, initially discovered in 2013, now metastatic with spread to lungs, liver, peritoneum, and ovary.\nPMH: Anxiety, hyperlipidemia.\nPrior cancer treatments: Mastectomy with sentinel node biopsy and implant reconstruction in 2013, declined tamoxifen and no chemotherapy or radiation.\nCurrent cancer treatments: Pending tissue confirmation, planning to start Ibrance if hormone receptor-positive upon reevaluation.\nCurrent medication list: Patient reported taking a long list of supplements, specifics not on file.\nSummary of most recent oncology visit (12/30/2019): 56-year-old female with a history of right breast cancer recently presenting with symptoms leading to the discovery of widespread metastatic disease. Comprehensive staging and biopsy scheduled to confirm tissue characteristics and plan treatment. Treatment to be palliative aimed at improving quality and length of life. Patient expressed fear and anxiety, supported by her husband at the visit. Referrals made for integrative medicine and a detailed planned follow-up after biopsy and staging results.\nAllergies: Penicillins (rash)."}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 2340, "completion_tokens": 238, "total_tokens": 2578}, "system_fingerprint": "fp_9d7f5c6195"}}, "error": null}
{"id": "batch_req_7fqiwP9tiSfI01pZiZHXnjLU", "custom_id": "1_coral_summary_1.0_gpt-4-turbo", "response": {"status_code": 200, "request_id": "e65fca45c61906e00152de7de895b81e", "body": {"id": "chatcmpl-9e3oNdMCIE4fzKE6ndOzByAbT9oC8", "object": "chat.completion", "created": 1719334799, "model": "gpt-4-turbo-2024-04-09", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Summary:\nAge: 44 years\nGender: Female\nCancer diagnosis: Early-stage endometrial and colon cancer, metastatic breast cancer\nPMH: Lynch syndrome, anemia due to malignancy and chemotherapy, peripheral neuropathy due to Abraxane, anxiety, hot flashes, chronic headaches, hyponatremia, hypokalemia, history of DVT\nPrior cancer treatments: Neoadjuvant therapy and weekly cycles of carboplatin/paclitaxel (discontinued due to poor tolerance), partial mastectomy, adjuvant therapy, gemcitabine + carboplatin for pectoral lymph nodes, local recurrence treated with Doxycycline, recent start of Irinotecan\nCurrent cancer treatments: Irinotecan (started 06/30/19, adjusted to every other week at 150mg/m\u00b2 on days 1 and 15 every 28 days)\nCurrent medication list: Albuterol, AMBIEN CR, cyclobenzaprine, diphenoxylate-atropine, docusate sodium, gabapentin, lidocaine-prilocaine, loperamide, lorazepam, lurasidone, magnesium oxide, morphine, omeprazole, ondansetron, oxycodone, polyethylene glycol, pregabalin, prochlorperazine, rivaroxaban, simethicone, venlafaxine (Effexor-XR)\nSummary of most recent oncology visit: 44-year-old female with Lynch Syndrome, early-stage endometrial and colon cancer, and newly diagnosed metastatic breast cancer, currently on adjusted dose of Irinotecan. Recent issues with chest wall pain and erythema treated with antibiotics and complications of severe anemia managed with a blood transfusion. Reports symptoms of anxiety, chronic headaches, peripheral neuropathy, sacral pain, and hyponatremia, addressing with various supportive medications and modifications in chemotherapy dosing. Upcoming scans scheduled for September 2019. Will continue current management and follow-up in 2 weeks."}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5742, "completion_tokens": 431, "total_tokens": 6173}, "system_fingerprint": "fp_5a244dacc1"}}, "error": null}
{"id": "batch_req_hQk8cK4W7nMgvqk9ei4ullAn", "custom_id": "2_coral_summary_1.0_gpt-4-turbo", "response": {"status_code": 200, "request_id": "5e43d93cbf79f8fb792a435e132db9da", "body": {"id": "chatcmpl-9e3okeaoEFgmxCS9VUIsimPHiGjj9", "object": "chat.completion", "created": 1719334822, "model": "gpt-4-turbo-2024-04-09", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Summary:\nAge: 53 years\nGender: Female\nCancer diagnosis: Stage IIA invasive ductal carcinoma (IDC) of the right breast, HR+ HER2- \nPMH: Hyperlipidemia, pre-diabetes\nPrior cancer treatments: None\nCurrent cancer treatments: Discussed neoadjuvant chemotherapy, surgery, radiation, and hormonal therapy\nCurrent medication list: None on file\nSummary of most recent oncology visit (08/31/2021): 53-year-old female presented for a new patient evaluation via telehealth. Diagnosed with Stage IIA HR+ HER2- IDC of the right breast. Genetic testing and PET CT pending. Discussed management with chemotherapy, surgery, radiation, and hormonal therapy to reduce risk of recurrence. Recommended lifestyle modifications for cancer risk reduction. Good support system noted. Follow-up planned after pending tests. No current medications or allergies reported. Non-smoker, no alcohol or drug use. Not currently sexually active."}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1640, "completion_tokens": 200, "total_tokens": 1840}, "system_fingerprint": "fp_5a244dacc1"}}, "error": null}
{"id": "batch_req_aWo3nvmAGl3WSefuugB7Hs92", "custom_id": "3_coral_summary_1.0_gpt-4-turbo", "response": {"status_code": 200, "request_id": "cd0465daf8a3205904302cc8fd3f7263", "body": {"id": "chatcmpl-9e3mTSS4gaB5buVyiIIluF5f2oeqG", "object": "chat.completion", "created": 1719334681, "model": "gpt-4-turbo-2024-04-09", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Summary:\n- Age: 75 years\n- Gender: Female\n- Cancer diagnosis: ER+/PR+/HER2- left breast invasive ductal carcinoma\n- PMH: hypertension, hypercholesterolemia, allergic rhinitis, hepatitis A, cataract surgery, colonoscopy\n- Prior cancer treatments: Left mastectomy with sentinel lymph node biopsy, Letrozole therapy since December 2016\n- Current cancer treatments: Letrozole 2.5 mg daily (since 12/02/2016)\n- Current medication list: aspirin 81 mg, calcium carbonate, vitamin D3 (cholecalciferol 1000 units), letrozol e, loratadine, metoprolol succinate, metoprolol tartrate, pravastatin\n- Summary of most recent oncology visit (6 months ago): 75-year-old female with history of left breast invasive ductal carcinoma, post-mastectomy, currently on Letrozole with no evidence of disease recurrence. Experiencing improved muscle cramping, back and thigh pain from physical therapy. Advised on magnesium supplement, and continuation of physical therapy for muscle tightness. Bone density scan showing improvement in femur neck, osteopenia in lumbar spine and femur stable, advised continuation of calcium and vitamin D supplements. Regular monitoring with DEXA scans recommended. Additionally, intermittent headaches and loose stools post-meals managed with OTC medications and dietary adjustments, advised follow-up with primary care for headache management if persistent. Counseled on recognizing alarming signs and when to seek urgent care. Follow-up visit scheduled in 6 months or sooner for new or worsening symptoms."}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 2752, "completion_tokens": 346, "total_tokens": 3098}, "system_fingerprint": "fp_9d7f5c6195"}}, "error": null}
{"id": "batch_req_kSqSZ1ODQrzab9F6MnVO4mpN", "custom_id": "4_coral_summary_1.0_gpt-4-turbo", "response": {"status_code": 200, "request_id": "aeeea71fd9933b9c61935da8c92572f2", "body": {"id": "chatcmpl-9e3mhqhxIjHJPyXG0orAu1VkL4nWi", "object": "chat.completion", "created": 1719334695, "model": "gpt-4-turbo-2024-04-09", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Summary:\n- Age: 31 years\n- Gender: Female\n- Cancer diagnosis: Recurrent metastatic invasive ductal carcinoma (IDC) of the left breast, Stage III, ER+/PR+/HER2-, with metastasis involving left cervical lymph node and left brachial plexus.\n- PMH: Premenopausal status.\n- Prior cancer treatments: Bilateral mastectomy with left axillary clearance, followed by adjuvant chemotherapy with Adriamycin and cyclophosphamide (stopped after 3 cycles due to severe side effects), anti-estrogen therapy (leuprolide, exemestane, tamoxifen).\n- Current cancer treatments: Leuprolide (since January 2019), Anastrozole (since March 2019), Palbociclib (since April 2019).\n- Current medication list: Amlodipine, Anastrozole, Escitalopram, Gabapentin, Hydrochlorothiazide, Ondansetron, Palbociclib, Potassium chloride, Venlafaxine.\n- Summary of most recent oncology visit (12/07/2019): 31-year-old female with a history of recurrent, metastatic IDC of the left breast, now involving left cervical lymph nodes and left brachial plexus. Continues on hormonal therapy with leuprolide, anastrozole, and palbociclib, showing controlled disease but with new osseous metastasis suspected in the sternum. Patient has been referred to radiation oncology for brachial plexus involvement and plans are in place for restaging studies prior to the next visit. The patient tolerates current therapies with supportive medications and will continue with scheduled monthly labs."}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 3407, "completion_tokens": 364, "total_tokens": 3771}, "system_fingerprint": "fp_5a244dacc1"}}, "error": null}
